The NMDA/D1 receptor complex as a new target in drug development.
about
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoringPreferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine.Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomersOlanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disordersGβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.Adaptive evolution and elucidating the potential inhibitor against schizophrenia to target DAOA (G72) isoforms.The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration.Regulation of Nociceptive Plasticity Threshold and DARPP-32 Phosphorylation in Spinal Dorsal Horn Neurons by Convergent Dopamine and Glutamate InputsD-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians.Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDSSubstrates dissociate dopamine transporter oligomers.Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticityCocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats.Ultrastructural relationships between cortical, thalamic, and amygdala glutamatergic inputs and group I metabotropic glutamate receptors in the rat accumbens.Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of diseaseHuman immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways.Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons.Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons.Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors.Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptorMorphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala.Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.
P2860
Q28754716-AE5B8F66-0936-434B-AE4D-293BFF5E8850Q30488760-4F9C031B-580D-4866-A780-199D383477BFQ33753132-5FA97525-4682-4E26-9E48-4853BDCB0855Q33986661-AF0FE3C7-6A94-436C-B3BB-22186D812EF1Q34020736-A3EFCFEA-4610-4C89-B503-E3EBB09B1FE9Q34536809-4D591CF3-387D-492D-AD95-273276762CD9Q35021488-D15490F9-F06F-4651-AF11-F6E2D4BB8E73Q35216295-C0204D06-6DF2-493B-84BD-ADE61A7BA7F0Q35678190-9F80115F-9896-47A0-97EB-3F316AD4E639Q35841574-2CD46764-F94B-4F87-B6ED-B60EE0BB448FQ36125572-44B39C3F-DC8B-425D-9304-0BBCFC0365C0Q36127739-D1475DA7-BAB0-4032-8BF1-40354A0333C3Q36297843-96DEC954-3184-46EE-AD66-54FA536ABD57Q36856162-BB03814E-7840-44EC-91B7-E13D9889F385Q37051785-8FB273D1-9C1A-4652-9204-FB03A680C57CQ37333350-D857A18F-0B4C-4FA6-8C4B-60B8BF10BBF2Q37394262-46CD7EB9-4278-4765-B202-B97F5A769411Q37493789-1E010975-7E33-4119-A074-C60DA639E639Q37996350-51515BB4-DC10-4B6C-966E-877C7EC9C9F5Q38122650-457E32C1-A773-498F-BF8A-931CDB90350CQ41838215-C5344068-91AE-470F-8BFE-094CAF06CCBCQ41863627-52F68824-6D10-419E-AE6C-84EE9D351072Q42325582-D4F164B1-C481-415F-B712-AA8DC8C9E293Q42408293-6CEE1FDF-7AD1-4C45-A33E-B70CB7E0E3B4Q46662287-FC69869E-2D5C-4A95-80C4-E4629A228E8EQ48316975-4E232F8B-FD02-4F99-BF88-EAC1E97CA0AF
P2860
The NMDA/D1 receptor complex as a new target in drug development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The NMDA/D1 receptor complex as a new target in drug development.
@ast
The NMDA/D1 receptor complex as a new target in drug development.
@en
type
label
The NMDA/D1 receptor complex as a new target in drug development.
@ast
The NMDA/D1 receptor complex as a new target in drug development.
@en
prefLabel
The NMDA/D1 receptor complex as a new target in drug development.
@ast
The NMDA/D1 receptor complex as a new target in drug development.
@en
P2093
P1476
The NMDA/D1 receptor complex as a new target in drug development
@en
P2093
Chiara Busi
Chiara Fiorentini
Cristina Missale
Ginetta Collo
P304
P356
10.2174/156802606777057562
P577
2006-01-01T00:00:00Z